Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Acupuncture tested for pain in underserved cancer survivors

NCT ID NCT06814977

Symptom relief Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether acupuncture is a practical option for cancer survivors who have ongoing joint pain. Researchers will enroll 60 racially diverse, underserved survivors and offer 10 weekly acupuncture sessions. The main goal is to see if people are willing to join and stick with the treatment, not yet to prove it reduces pain.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acupuncture
What this could lead to
If this works, it could offer a safe, non-drug option for managing chronic pain in cancer survivors, especially those with limited access to care.
What could go wrong
This is a small, early feasibility study (60 people) — it is not designed to prove acupuncture works, only whether it can be studied. Results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * English- or Spanish-speaking adults * Non white or Hispanic women with a prior cancer diagnosis * Stable oncological disease or no evidence oncological of disease per clinical documentation or clinician assessment * Worst pain rated ≥4 on a 0-10 scale in the preceding week * ≥15 days with pain in the past 30 days * Pain lasting ≥1 month * Willing and able to complete questionnaires and other study activities * Willing and able to provide informed consent for the trial Exclusion Criteria: * Completed active treatment (chemotherapy, surgery, radiation, transplantation) \<4 weeks prior to study * Maintenance therapies are allowed * Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout) * Other non-musculoskeletal pain syndromes (eg, headache, visceral abdominal pain, neuropathic pain) can be present as comorbid conditions if the patient reports musculoskeletal pain as the primary source of pain * Procedures involving affected joints within the last month or planned in the next 14 weeks * Acupuncture use for pain in the past three months * Implanted electronic device (e.g., pacemaker)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer survivor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer survivor

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Jamaica Hospital Medical Center

    RECRUITING

    Richmond Hill, New York, 11418, United States

  • Memorial Sloan Kettering Cancer Center (All protocol activites)

    RECRUITING

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.